Salicylate-induced degeneration of cochlea spiral ganglion neurons-apoptosis signaling

Neuroscience

Volumn 168, Issue 1, 2010, Pages 288-299

  Wei, L ^a   Ding, D ^a   Salvi, R ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Aspirin; Caspase; NF B; Organotypic culture; PCR array; Tumor necrosis factor

Indexed keywords

ADAPTOR PROTEIN; APOPTOSIS ASSOCIATED SPECK LIKE PROTEIN CONTAINING A CASPASE RECRUITMENT DOMAIN; APOPTOSIS REPRESSOR WITH CASPASE RECRUITMENT DOMAIN; BACULOVIRAL INHIBITOR OF APOPTOSIS PROTEIN REPEAT CONTAINING PROTEIN 3; CASPASE; CASPASE 7; CASPASE RECRUITMENT DOMAIN PROTEIN 10; CD40 ANTIGEN; CELL DEATH INDUCING DNA FRAGMENTATION FACTOR LIKE EFFECTOR B; DEATH ASSOCIATED PROTEIN KINASE; FAS ANTIGEN; GENE PRODUCT; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; LYMPHOTOXIN; LYMPHOTOXIN BETA RECEPTOR; PROKINETICIN 2; PROTEIN P53; SALICYLIC ACID; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR LHX4; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL DEATH; COCHLEA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENETIC ANALYSIS; HAIR CELL; NERVE CELL; NERVE CELL DEGENERATION; NERVE CELL LESION; NEWBORN; NONHUMAN; OTOTOXICITY; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN FAMILY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPIRAL GANGLION; TISSUE CULTURE; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASES; CELL SIZE; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SODIUM SALICYLATE; SPIRAL GANGLION;

EID: 77952890758     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.03.015     Document Type: Article

References (104)

1. Abe T., Kakehata S., Kitani R., Maruya S., Navaratnam D., Santos-Sacchi J., Shinkawa H. Developmental expression of the outer hair cell motor prestin in the mouse. J Membr Biol 2007, 215:49-56.
2. Aggarwal B.B., Aiyer R.A., Pennica D., Gray P.W., Goeddel D.V. Human tumour necrosis factors: structure and receptor interactions. Ciba Found Symp 1987, 131:39-51.
3. Aggarwal B.B., Eessalu T.E., Hass P.E. Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon. Nature 1985, 318:665-667.
4. Almasan A., Ashkenazi A. Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev 2003, 14:337-348.
5. Baldwin A.S. Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest 2001, 107:3-6.
6. Basta D., Ernst A. Effects of salicylate on spontaneous activity in inferior colliculus brain slices. Neurosci Res 2004, 50:237-243.
7. Basta D., Goetze R., Ernst A. Effects of salicylate application on the spontaneous activity in brain slices of the mouse cochlear nucleus, medial geniculate body and primary auditory cortex. Hear Res 2008, 240:42-51.
8. Boettcher F.A., Bancroft B.R., Salvi R.J. Concentration of salicylate in serum and perilymph of the chinchilla. Arch Otolaryngol Head Neck Surg 1990, 116:681-684.
9. Boettcher F.A., Salvi R.J. Salicylate ototoxicity: review and synthesis. Am J Otolaryngol 1991, 12:33-47.
10. Bortner C.D., Cidlowski J.A. A necessary role for cell shrinkage in apoptosis. Biochem Pharmacol 1998, 56:1549-1559.
11. Cazals Y. Auditory sensori-neural alterations induced by salicylate. Prog Neurobiol 2000, 62:583-631.
12. Chen G.-D., Habiby Kermany M., D'Elia A., Ralli M., Tanaka C., Bielefeld E.C., Ding D., Henderson D., Salvi R. Too much of a good thing: long-term treatment with salicylate strengthens outer hair cell function but impairs auditory neural activity. Hear Res 2010, Mar 11, [Epub ahead of print].
13. Chen G.D., Jastreboff P.J. Salicylate-induced abnormal activity in the inferior colliculus of rats. Hear Res 1995, 82:158-178.
14. Chen X., Kandasamy K., Srivastava R.K. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling. Cancer Res 2003, 63:1059-1066.
15. Chen Z., Guo K., Toh S.Y., Zhou Z., Li P. Mitochondria localization and dimerization are required for CIDE-B to induce apoptosis. J Biol Chem 2000, 275:22619-22622.
16. Cheng M.Y., Bullock C.M., Li C., Lee A.G., Bermak J.C., Belluzzi J., Weaver D.R., Leslie F.M., Zhou Q.Y. Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature 2002, 417:405-410.
17. Cheng T.O. The history of aspirin. Tex Heart Inst J 2007, 34:392-393.
18. Cohen G.M. Caspases: the executioners of apoptosis. Biochem J 1997, 326(Pt 1):1-16.
19. Crowe P.D., VanArsdale T.L., Walter B.N., Ware C.F., Hession C., Ehrenfels B., Browning J.L., Din W.S., Goodwin R.G., Smith C.A. A lymphotoxin-beta-specific receptor. Science 1994, 264:707-710.
20. Degli-Esposti M. To die or not to die-the quest of the TRAIL receptors. J Leukoc Biol 1999, 65:535-542.
21. Devin A., Cook A., Lin Y., Rodriguez Y., Kelliher M., Liu Z. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 2000, 12:419-429.
22. Ding D., Jiang H., Wang P., Salvi R. Cell death after co-administration of cisplatin and ethacrynic acid. Hear Res 2007, 226:129-139.
23. Ding D., McFadden S., Salvi R.J. Cochlear hair cell densities and inner ear staining techniques. The auditory psychobiology of the mouse 2001, 189-204. CRC Press, Boca Raton. J.E. Willott (Ed.).
24. Ding D., Stracher A., Salvi R.J. Leupeptin protects cochlear and vestibular hair cells from gentamicin ototoxicity. Hear Res 2002, 164:115-126.
25. Dutta J., Fan Y., Gupta N., Fan G., Gelinas C. Current insights into the regulation of programmed cell death by NF-kappaB. Oncogene 2006, 25:6800-6816.
26. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998, 391:43-50.
27. Feinstein E., Druck T., Kastury K., Berissi H., Goodart S.A., Overhauser J., Kimchi A., Huebner K. Assignment of DAP1 and DAPK-genes that positively mediate programmed cell death triggered by IFN-gamma-to chromosome regions 5p122 and 9q341, respectively. Genomics 1995, 29:305-307.
28. Friis M.B., Friborg C.R., Schneider L., Nielsen M.B., Lambert I.H., Christensen S.T., Hoffmann E.K. Cell shrinkage as a signal to apoptosis in NIH 3T3 fibroblasts. J Physiol 2005, 567:427-443.
29. Gao W.Q. Role of neurotrophins and lectins in prevention of ototoxicity. Ann N Y Acad Sci 1999, 884:312-327.
30. Ghosh S., May M.J., Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998, 16:225-260.
31. Green G.A. Understanding NSAIDs: from aspirin to COX-2. Clin Cornerstone 2001, 3:50-60.
32. Gross J., Machulik A., Amarjargal N., Fuchs J., Mazurek B. Expression of prestin mRNA in the organotypic culture of rat cochlea. Hear Res 2005, 204:183-190.
33. Guitton M.J., Caston J., Ruel J., Johnson R.M., Pujol R., Puel J.L. Salicylate induces tinnitus through activation of cochlear NMDA receptors. J Neurosci 2003, 23:3944-3952.
34. Haupt S., Berger M., Goldberg Z., Haupt Y. Apoptosis - the p53 network. J Cell Sci 2003, 116:4077-4085.
35. Heard K.J., Ries N.L., Dart R.C., Bogdan G.M., Zallen R.D., Daly F. Overuse of non-prescription analgesics by dental clinic patients. BMC Oral Health 2008, 8:33.
36. Hoek K.S., Schlegel N.C., Eichhoff O.M., Widmer D.S., Praetorius C., Einarsson S.O., Valgeirsdottir S., Bergsteinsdottir K., Schepsky A., Dummer R., Steingrimsson E. Novel MITF targets identified using a two-step DNA microarray strategy. Pigment Cell Melanoma Res 2008, 21:665-676.
37. Hollander M.C., Alamo I., Jackman J., Wang M.G., McBride O.W., Fornace A.J. Analysis of the mammalian gadd45 gene and its response to DNA damage. J Biol Chem 1993, 268:24385-24393.
38. Houde C., Banks K.G., Coulombe N., Rasper D., Grimm E., Roy S., Simpson E.M., Nicholson D.W. Caspase-7 expanded function and intrinsic expression level underlies strain-specific brain phenotype of caspase-3-null mice. J Neurosci 2004, 24:9977-9984.
39. Hsu H., Huang J., Shu H.B., Baichwal V., Goeddel D.V. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 1996, 4:387-396.
40. Huang Z.W., Luo Y., Wu Z., Tao Z., Jones R.O., Zhao H.B. Paradoxical enhancement of active cochlear mechanics in long-term administration of salicylate. J Neurophysiol 2005, 93:2053-2061.
41. Imai Y., Kimura T., Murakami A., Yajima N., Sakamaki K., Yonehara S. The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis. Nature 1999, 398:777-785.
42. Isobe M., Emanuel B.S., Givol D., Oren M., Croce C.M. Localization of gene for human p53 tumour antigen to band 17p13. Nature 1986, 320:84-85.
43. Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S., Sameshima M., Hase A., Seto Y., Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991, 66:233-243.
44. Jastreboff P.J., Brennan J.F., Coleman J.K., Sasaki C.T. Phantom auditory sensation in rats: an animal model for tinnitus. Behav Neurosci 1988, 102:811-822.
45. Jastreboff P.J., Hansen R., Sasaki P.G., Sasaki C.T. Differential uptake of salicylate in serum, cerebrospinal fluid, and perilymph. Arch Otolaryngol Head Neck Surg 1986, 112:1050-1053.
46. Jung T.T., Rhee C.K., Lee C.S., Park Y.S., Choi D.C. Ototoxicity of salicylate, nonsteroidal antiinflammatory drugs, and quinine. Otolaryngol Clin North Am 1993, 26:791-810.
47. Kakehata S., Santos-Sacchi J. Effects of salicylate and lanthanides on outer hair cell motility and associated gating charge. J Neurosci 1996, 16:4881-4889.
48. Kasibhatla S., Genestier L., Green D.R. Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB. J Biol Chem 1999, 274:987-992.
49. Kern S.E., Kinzler K.W., Bruskin A., Jarosz D., Friedman P., Prives C., Vogelstein B. Identification of p53 as a sequence-specific DNA-binding protein. Science 1991, 252:1708-1711.
50. Koseki T., Inohara N., Chen S., Nunez G. ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proc Natl Acad Sci U S A 1998, 95:5156-5160.
51. Kucharczak J., Simmons M.J., Fan Y., Gelinas C. To be, or not to be: NF-kappaB is the answer-role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 2003, 22:8961-8982.
52. Larsen S.U. Reye's syndrome. Med Sci Law 1997, 37:235-241.
53. Lemberg A., Fernandez M.A., Coll C., Rosello D.O., Romay S., Perazzo J.C., Filinger E.J. Reyes's syndrome, encephalopathy, hyperammonemia and acetyl salicylic acid ingestion in a city hospital of Buenos Aires, Argentina. Curr Drug Saf 2009, 4:17-21.
54. Levine M., Wong D., Brown D.F., Nadel E.S. Chest pain and arthritis. J Emerg Med 2005, 29:91-95.
55. Levine M.S., Verstandig A., Laufer I. Serpiginous gastric erosions caused by aspirin and other nonsteroidal antiinflammatory drugs. AJR Am J Roentgenol 1986, 146:31-34.
56. Lewis H.D., Davis J.W., Archibald D.G., Steinke W.E., Smitherman T.C., Doherty J.E., Schnaper H.W., LeWinter M.M., Linares E., Pouget J.M., Sabharwal S.C., Chesler E., DeMots H. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a veterans administration cooperative study. N Engl J Med 1983, 309:396-403.
57. Liu X., Zou H., Slaughter C., Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997, 89:175-184.
58. Liu Y., Fan M., Yu S., Zhou Y., Wang J., Yuan J., Qiang B. cDNA cloning, chromosomal localization and expression pattern analysis of human LIM-homeobox gene LHX4. Brain Res 2002, 928:147-155.
59. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
60. Lobarinas E., Yang G., Sun W., Ding D., Mirza N., Dalby-Brown W., Hilczmayer E., Fitzgerald S., Zhang L., Salvi R. Salicylate- and quinine-induced tinnitus and effects of memantine. Acta Otolaryngol Suppl 2006, 126:13-19.
61. Loveridge C.J., MacDonald A.D., Thoms H.C., Dunlop M.G., Stark L.A. The proapoptotic effects of sulindac, sulindac sulfone and indomethacin are mediated by nucleolar translocation of the RelA(p65) subunit of NF-kappaB. Oncogene 2008, 27:2648-2655.
62. Lugovskoy A.A., Zhou P., Chou J.J., McCarty J.S., Li P., Wagner G. Solution structure of the CIDE-N domain of CIDE-B and a model for CIDE-N/CIDE-N interactions in the DNA fragmentation pathway of apoptosis. Cell 1999, 99:747-755.
63. MacFarlane M. TRAIL-induced signalling and apoptosis. Toxicol Lett 2003, 139:89-97.
64. Machinis K., Pantel J., Netchine I., Leger J., Camand O.J., Sobrier M.L., Dastot-Le Moal F., Duquesnoy P., Abitbol M., Czernichow P., Amselem S. Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. Am J Hum Genet 2001, 69:961-968.
65. Maeno E., Ishizaki Y., Kanaseki T., Hazama A., Okada Y. Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. Proc Natl Acad Sci U S A 2000, 97:9487-9492.
66. Malinin N.L., Boldin M.P., Kovalenko A.V., Wallach D. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature 1997, 385:540-544.
67. Masumoto J., Taniguchi S., Ayukawa K., Sarvotham H., Kishino T., Niikawa N., Hidaka E., Katsuyama T., Higuchi T., Sagara J. ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells. J Biol Chem 1999, 274:33835-33838.
68. Matlashewski G., Lamb P., Pim D., Peacock J., Crawford L., Benchimol S. Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene. EMBO J 1984, 3:3257-3262.
69. McAllister-Lucas L.M., Inohara N., Lucas P.C., Ruland J., Benito A., Li Q., Chen S., Chen F.F., Yamaoka S., Verma I.M., Mak T.W., Nunez G. Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction. J Biol Chem 2001, 276:30589-30597.
70. McCabe P.A., Dey F.L. The effect of aspirin upon auditory sensitivity. Ann Otol Rhinol Laryngol 1965, 74:312-325.
71. McDade T.P., Perugini R.A., Vittimberga F.J., Carrigan R.C., Callery M.P. Salicylates inhibit NF-kappaB activation and enhance TNF-alpha-induced apoptosis in human pancreatic cancer cells. J Surg Res 1999, 83:56-61.
72. McFadden D., Plattsmier H.S., Pasanen E.G. Temporary hearing loss induced by combinations of intense sounds and nonsteroidal anti-inflammatory drugs. Am J Otolaryngol 1984, 5:235-241.
73. McFadden S.L., Ding D., Salvemini D., Salvi R.J. M40403, a superoxide dismutase mimetic, protects cochlear hair cells from gentamicin, but not cisplatin toxicity. Toxicol Appl Pharmacol 2003, 186:46-54.
74. Myers E.N., Bernstein J.M. Salicylate ototoxicity; a clinical and experimental study. Arch Otolaryngol 1965, 82:483-493.
75. Myers E.N., Bernstein J.M., Fostiropolous G. Salicylate ototoxicity: a clinical study. N Engl J Med 1965, 273:587-590.
76. Nagata S. Fas ligand-induced apoptosis. Annu Rev Genet 1999, 33:29-55.
77. Ng K.L., Li J.D., Cheng M.Y., Leslie F.M., Lee A.G., Zhou Q.Y. Dependence of olfactory bulb neurogenesis on prokineticin 2 signaling. Science 2005, 308:1923-1927.
78. Okada Y., Maeno E., Shimizu T., Dezaki K., Wang J., Morishima S. Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD). J Physiol 2001, 532:3-16.
79. Oshimi Y., Oda S., Honda Y., Nagata S., Miyazaki S. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J Immunol 1996, 157:2909-2915.
80. Pan G., O'Rourke K., Chinnaiyan A.M., Gentz R., Ebner R., Ni J., Dixit V.M. The receptor for the cytotoxic ligand TRAIL. Science 1997, 276:111-113.
81. Park-Min K.H., Ji J.D., Antoniv T., Reid A.C., Silver R.B., Humphrey M.B., Nakamura M., Ivashkiv L.B. IL-10 suppresses calcium-mediated costimulation of receptor activator NF-kappa B signaling during human osteoclast differentiation by inhibiting TREM-2 expression. J Immunol 2009, 183:2444-2455.
82. Peng B.G., Chen S., Lin X. Aspirin selectively augmented N-methyl-d-aspartate types of glutamate responses in cultured spiral ganglion neurons of mice. Neurosci Lett 2003, 343:21-24.
83. Perkins N.D. The Rel/NF-kappa B family: friend and foe. Trends Biochem Sci 2000, 25:434-440.
84. Puel J.L. Cochlear NMDA receptor blockade prevents salicylate-induced tinnitus. B-ENT 2007, 3(Suppl 7):19-22.
85. Ruel J., Chabbert C., Nouvian R., Bendris R., Eybalin M., Leger C.L., Bourien J., Mersel M., Puel J.L. Salicylate enables cochlear arachidonic-acid-sensitive NMDA receptor responses. J Neurosci 2008, 28:7313-7323.
86. Ryan K.M., Ernst M.K., Rice N.R., Vousden K.H. Role of NF-kappaB in p53-mediated programmed cell death. Nature 2000, 404:892-897.
87. Sakahira H., Enari M., Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 1998, 391:96-99.
88. Schuknecht H.F. Auditory and cytocochlear correlates of inner ear disorders. Otolaryngol Head Neck Surg 1994, 110:530-538.
89. Starr A., Picton T.W., Sininger Y., Hood L.J., Berlin C.I. Auditory neuropathy. Brain 1996, 119:741-753.
90. Stoss O., Schwaiger F.W., Cooper T.A., Stamm S. Alternative splicing determines the intracellular localization of the novel nuclear protein Nop30 and its interaction with the splicing factor SRp30c. J Biol Chem 1999, 274:10951-10962.
91. Sun W., Lu J., Stolzberg D., Gray L., Deng A., Lobarinas E., Salvi R.J. Salicylate increases the gain of the central auditory system. Neuroscience 2009, 159:325-334.
92. Trost L.C., Lemasters J.J. The mitochondrial permeability transition: a new pathophysiological mechanism for Reye's syndrome and toxic liver injury. J Pharmacol Exp Ther 1996, 278:1000-1005.
93. Trost L.C., Lemasters J.J. Role of the mitochondrial permeability transition in salicylate toxicity to cultured rat hepatocytes: implications for the pathogenesis of Reye's syndrome. Toxicol Appl Pharmacol 1997, 147:431-441.
94. van Kooten C., Banchereau J. CD40-CD40 ligand. J Leukoc Biol 2000, 67:2-17.
95. Vonweiss J.F., Lever W.F. Percutaneous salicylic acid Intoxication in psoriasis. Arch Dermatol 1964, 90:614-619.
96. Waltner J.G. The effect of salicylates on the inner ear. Ann Otol Rhinol Laryngol 1955, 64:617-622.
97. Wang H.T., Luo B., Zhou K.Q., Xu T.L., Chen L. Sodium salicylate reduces inhibitory postsynaptic currents in neurons of rat auditory cortex. Hear Res 2006, 215:77-83.
98. Wang L., Manji G.A., Grenier J.M., Al-Garawi A., Merriam S., Lora J.M., Geddes B.J., Briskin M., DiStefano P.S., Bertin J. PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-kappa B and caspase-1-dependent cytokine processing. J Biol Chem 2002, 277:29874-29880.
99. Wyllie A.H., Kerr J.F., Currie A.R. Cell death: the significance of apoptosis. Int Rev Cytol 1980, 68:251-306.
100. Xu Y., Song G. The role of CD40-CD154 interaction in cell immunoregulation. J Biomed Sci 2004, 11:426-438.
101. Yang G., Lobarinas E., Zhang L., Turner J., Stolzberg D., Salvi R., Sun W. Salicylate induced tinnitus: behavioral measures and neural activity in auditory cortex of awake rats. Hear Res 2007, 226:244-253.
102. Yang K., Huang Z.W., Liu Z.Q., Xiao B.K., Peng J.H. Long-term administration of salicylate enhances prestin expression in rat cochlea. Int J Audiol 2009, 48:18-23.
103. Yu N., Zhu M.L., Johnson B., Liu Y.P., Jones R.O., Zhao H.B. Prestin up-regulation in chronic salicylate (aspirin) administration: an implication of functional dependence of prestin expression. Cell Mol Life Sci 2008, 65:2407-2418.
104. Zheng X.Y., Henderson D., Hu B.H., McFadden S.L. Recovery of structure and function of inner ear afferent synapses following kainic acid excitotoxicity. Hear Res 1997, 105:65-76.